Company Overview and News

 
Freedom Mobile and TransLink Partner to Provide Wireless Connectivity in SkyTrain Dunsmuir Tunnel

6h globenewswire
Freedom Mobile customers can now talk, text and stream while riding the SkyTrain between Waterfront and Stadium-Chinatown stations

 
Shaw Communications Completes Its First Successful 5G Technical Trials

2018-05-22 globenewswire
CALGARY, Alberta, May 22, 2018 (GLOBE NEWSWIRE) -- Shaw Communications Inc. (TSX:SJR.B) (TSX:SJR.PR.A) (TSX:SJR.PR.B) (NYSE:SJR) (TSX-V:SJR.A) today announced the successful completion of its first 5G technical trials in Calgary. Conducted in collaboration with Nokia, CableLabs and Rohde & Schwarz, Shaw’s trials leveraged 28GHz mmWave and 3.5GHz spectrum and demonstrated the significant and sustained speeds for the next generation of wireless technology.

 
Why is Celanese (CE) Up 1.7% Since Last Earnings Report?

2018-05-16 zacks
It has been about a month since the last earnings report for Celanese Corporation (CE - Free Report) . Shares have added about 1.7% in that time frame.

 
Why is BofA (BAC) Up 4% Since Last Earnings Report?

2018-05-16 zacks
It has been about a month since the last earnings report for Bank of America Corporation (BAC - Free Report) . Shares have added about 4% in that time frame.

 
Shaw Communications (SJR) Down 2.3% Since Earnings Report: Can It Rebound?

2018-05-14 zacks
A month has gone by since the last earnings report for Shaw Communications Inc. (SJR - Free Report) . Shares have lost about 2.3% in that time frame.

 
Competition Bureau to 'shine a light' on internet industry with market study

2018-05-10 cbc.ca
The federal competition watchdog says he wants to "shine a light" on Canada's broadband internet providers with the public's comments on a market that is predominantly served by traditional phone and cable companies.

 
New name could be in the works for Edmonton's Shaw Conference Centre

2018-05-01 cbc.ca
The Shaw Conference Centre, one of the most distinctive buildings in downtown Edmonton, could get a new name.

 
Should You Buy Cogeco Communications And Its Growing Dividend?

2018-04-27 seekingalpha
Cogeco Communications is the fourth-largest cable company in Canada and owns quality cable assets in the United States.

 
2 High-Yield Blue Chips Worth Buying Today But One Is Far More Likely To Beat The Market

2018-04-26 seekingalpha
Telecom has had a rough year, largely thanks to concerns over cord cutting, a price war in wireless, and rising interest rates.

 
Is Shaw Communications A Good Long-Term Investment Choice?

2018-04-23 seekingalpha
Shaw Communications is a leading cable operator in Western Canada and currently, the fourth largest wireless communication service provider in the country.

 
Top Stock Reports for UnitedHealth, Netflix & Caterpillar

2018-04-18 zacks
The Zacks Research Daily presents the best research output of our analyst team. Today's Research Daily features new research reports on 16 major stocks, including UnitedHealth (UNH), Netflix (NFLX) and Caterpillar (CAT). These research reports have been hand-picked from the roughly 70 reports published by our analyst team today.

 
Second Cup Coffee Chain Looks To Add Marijuana

2018-04-18 seekingalpha
Second Cup $3.61 (Toronto symbol SCU, (OTC:SCUPF); Shares outstanding: 17.04 million; Market cap: $61.52 million; www.secondcup.com) is a Canada-based specialty coffee retailer with 286 cafes of which 12 are company-operated and the remaining are operated by franchisees.

 
Rogers Communications (RCI) Q1 Earnings: What's in Store?

2018-04-17 zacks
Rogers Communications Inc. (RCI - Free Report) is set to release first-quarter 2018 results on Apr 19. The company beat the Zacks Consensus Estimate in the trailing four quarters, with an average positive surprise of 4.97%. In fourth-quarter 2017, earnings of 69 cents per share outpaced the Zacks Consensus Estimate by a penny. Although revenues of $2.86 billion lagged the consensus mark, the figure increased 3% year over year driven by solid result from the Wireless segment.

 
Can TransDigm Maintain Impressive Momentum Amid Risks?

2018-04-16 zacks
TransDigm Group Inc. (TDG - Free Report) has managed to impress investors with its recent earnings streak, wherein the company’s bottom line has trumped estimates thrice in the trailing four quarters. TransDigm’s impressive business model actively works toward strengthening and enhancing its position in highly-engineered proprietary aerospace components’ niche markets.

 
Here's Why You Should Buy Universal Forest (UFPI) Stock Now

2018-04-16 zacks
We believe that Universal Forest Products, Inc. (UFPI - Free Report) is a solid choice for investors, seeking exposure in the building products space. Strengthening product portfolio, rising demand for repair and remodeling activities, healthy housing starts and synergistic benefits from acquired assets will be advantageous for the company. The stock, with approximately $2 billion market capitalization, has been upgraded to a Zacks Rank #1 (Strong Buy) on Apr 14.

Related Articles

ANTH: Anthera Pharmaceuticals Analysis and Research Report

2018-05-21 - Asif

Overview Anthera Pharmaceuticals, Inc. is a biopharmaceutical company focused on advancing the development and commercialization of innovative medicines that benefit patients with unmet medical needs. The company currently have two compounds in development, Sollpura and blisibimod. The company licensed Sollpura from Eli Lilly & Co (“Eli Lilly”) in July 2014. Sollpura is a novel non-porcine investigational Pancreatic Enzyme Replacement Therapy (“PERT”) intended for the treatment of patients with Exocrine Pancreatic Insufficiency (“EPI”), often seen in patients with cystic fibrosis and other conditions. The company licensed blisibimod from Amgen, Inc. (“Amgen”) in December 2007. Blisibimod targets B-cell activating factor, or BAFF, which has been shown to be elevated in a variety of B-cell mediated autoimmune diseases, including Immunoglobulin A nephropathy, or IgA nephropathy. Sollpura The exocrine pancreas is responsible for synthesis and secretion of digestive en...

AGEN: Agenus Inc Analysis and Research Report

2018-05-21 - Asif

Business Agenus is a clinical-stage immuno-oncology (“I-O”) company dedicated to becoming a leader in the discovery and development of innovative combination therapies and committed to bringing effective medicines to patients with cancer. The company's business is designed to drive success in I-O through speed, innovation, and effective combination therapies. Agenus has assembled fully integrated capabilities from novel target discovery, antibody generation, cell line development, and good manufacturing practice (“GMP”) manufacturing together with a comprehensive portfolio consisting of antibody-based therapeutics, adjuvants and cancer vaccine platforms. The company leverage its immune biology platforms to identify effective combination therapies for development and have developed productive partnerships to advance its innovation. The company believe the next generation of cancer treatment will build on clinically validated antibodies targeting CTLA-4 and PD-1 combined wi...

SQ: Square Analysis and Research Report

2018-05-21 - Asif

Business The company started Square in February 2009 to enable businesses (sellers) to accept card payments, an important capability that was previously inaccessible to many businesses. However, sellers also need innovative solutions to thrive, and Square has since expanded to provide additional products and services to give these businesses access to the same tools as large businesses. This approach aligns with its purpose of economic empowerment, as everything the company do should give sellers accessible, affordable tools to grow their businesses and participate in the economy. Square is a cohesive commerce ecosystem that helps its sellers start, run, and grow their businesses. The company combine sophisticated software with affordable hardware to enable sellers to turn mobile and computing devices into powerful payment and point-of-sale solutions. Square has high seller acceptance rates and fast onboarding, while maintaining low risk and fraud losses as a result of its a...

CUSIP: 82028K101